N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling

N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling

Huamei Wei,1,* Lizheng Huang,2,* Qi Lu,2,* Zheng Huang,2 Yanyan Huang,2 Zuoming Xu,3 Wenchuan Li,3 Jian Pu3,4 1Department of Pathology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People’s Republic of China; 2Graduate College of Youjiang Medic...

Full description

Bibliographic Details
Main Authors: Wei H, Huang L, Lu Q, Huang Z, Huang Y, Xu Z, Li W, Pu J
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
n6-methyladenosine
histone methylation
wnt/β-catenin signaling
Online Access:https://www.dovepress.com/n6-methyladenosine-modified-leawbih-drives-hepatocellular-carcinoma-pr-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/n6-methyladenosine-modified-leawbih-drives-hepatocellular-carcinoma-pr-peer-reviewed-fulltext-article-JHC

Similar Items